<code id='66DA0F8781'></code><style id='66DA0F8781'></style>
    • <acronym id='66DA0F8781'></acronym>
      <center id='66DA0F8781'><center id='66DA0F8781'><tfoot id='66DA0F8781'></tfoot></center><abbr id='66DA0F8781'><dir id='66DA0F8781'><tfoot id='66DA0F8781'></tfoot><noframes id='66DA0F8781'>

    • <optgroup id='66DA0F8781'><strike id='66DA0F8781'><sup id='66DA0F8781'></sup></strike><code id='66DA0F8781'></code></optgroup>
        1. <b id='66DA0F8781'><label id='66DA0F8781'><select id='66DA0F8781'><dt id='66DA0F8781'><span id='66DA0F8781'></span></dt></select></label></b><u id='66DA0F8781'></u>
          <i id='66DA0F8781'><strike id='66DA0F8781'><tt id='66DA0F8781'><pre id='66DA0F8781'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:25
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Congress likely to miss an opportunity to fix drug shortages issue
          Congress likely to miss an opportunity to fix drug shortages issue

          LeeKlafczynskiforSTATWASHINGTON—Congressisconsideringamust-passpandemicpreparednessbillthatpresentsa

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Involuntary treatment for addiction doesn't work

          ApersonpointstoadiscardedneedleinalotintheSouthBronx,NewYork.SpencerPlatt/GettyImagesAstheoverdosecr